Pakistan latest patents query
The latest invention patents collect the data information of Pakistan invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
Oxidative decolorization of dyes with enzymatically generated peracid
UndeterminedPK201000156A0
Owner:DANISCO US INC
A process of preparation of biopesticide from Photorhabdus luminescens against Galleria mellonella larvae and subteranean termite (Termitidae: Macrotermis)
UndeterminedPK140580A
Owner:SHAHINA FAYYAZ +3
Process for generating hydrogen and carbon dioxid from a hydrocarbon feedstock
UndeterminedPK201000228A0
Owner:HYDROGEN ENERGY INT
Addition salts of amines containing hydroxyl and / or car boxylic groups with amino nicotinic acid berivatives as dhodh inhibitors
UndeterminedPK201000196A0
Owner:ALMIRALL SA
3-substituted 5- and 6-aminoalkyl-indole-2-carboxylic acid amide compound
UndeterminedPK140668A
Owner:AVENTIS PHARMACEUTICALS INC
Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
UndeterminedPK201000194A0
Owner:ALMIRALL SA
Stable high protein concentration formulations of human anti -alpha antibodies
UndeterminedPK201000368A0
Owner:ABBVIE BIOTECHNOLOGY LTD
Transgenic rice event 17314 and methods of use thereof
UndeterminedPK201000254A0
Owner:MONSANTO TECHNOLOGY LLC
A process for the detection of clarithromycin-resistant strains of Helicobacter pylori
UndeterminedPK140680A
Owner:SAGHEER AHMED
New therapeutic agents for management of pain and inflammation from mallotus philippinensis
UndeterminedPK201000252A0
Owner:INAMULLAH KHAN +3
A cost effective process for the detection of ph value in soil water
UndeterminedPK201000326A0
Owner:MUSARRAT AKHTER
Therapeutic applications of quinazolinedione derivatives
UndeterminedPK201000293A0
Owner:SANOFI AVENTIS SA
Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medicinal products
UndeterminedPK201000267A0
Owner:PIERRE FABRE MEDICAMENT SAS
A method for detecting a point mutation in a gene of interest using pcr
UndeterminedPK140752A
Owner:SYNGENTA IP
Methods of administering (4ar,10ar)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzol[g]quinoline-6,7-diol and pharmaceutical compositions thereof.
UndeterminedPK201000148A0
Owner:H LUNDBECK AS
A process for the preparation of beverage precursor comprising tea material and food-grade additive
UndeterminedPK201000168A0
Owner:UNILEVER PLC
Apparatus for generating a stereo audio signal from waterborne sound signals
UndeterminedPK140761A
Owner:ATLAS ELEKTRONIK GMBH
Compositions and methods for antibodies targeting complement protein c3b
UndeterminedPK201000377A0
Owner:NOVARTIS AG
Substituted 1 cyanoethylheterocyclylcarboxamide compounds 750
UndeterminedPK201000384A0
Owner:ASTRAZENECA AB
Freeze-dried bacterial cell powder and method of producing the same
UndeterminedPK201000166A0
Owner:MEIJI CO LTD
N-[(7-azabicyclo[2.2.1]hept-1-yl) aryl-methyl]benzamide derivatives, preparation thereof and therapeutic use thereof
UndeterminedPK201000305A0
Owner:SANOFI AVENTIS SA
Process for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindoline
UndeterminedPK140774A
Owner:CELGENE CORP
A communication device for secure transaction system
UndeterminedPK201000409A0
Owner:JOHN FRANCO FARNCHI
Novel indazole derivatives which inhibit hsp90, compositions containing them and use thereof
UndeterminedPK201000220A0
Owner:SANOFI AVENTIS SA
Dyestuff comprising substituted phenylazo cyanomethyl ester compound
UndeterminedPK140689A
Owner:DYSTAR TEXTILFARBEN GMBH & CO DEUTSCHLAND KG
Sustained release oral formulation of vinpocetine
UndeterminedPK201000173A0
Owner:PATEL DINESH SHANTILAL +2
Substituted tetrahydropyrimido[4,5-b][1,4]-5h-diazepin-2-ylamino-methyl piperidin-4-yl benzamide compound
UndeterminedPK140783A
Owner:TAKEDA PHARMA CO LTD
Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
UndeterminedPK201000422A0
Owner:MERCK SHARP & DOHME CORP
An acid-addition salt of 3-disubstituted indol-2-one compound.
UndeterminedPK140662A
Owner:SANOFI AVENTIS SA
New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives.
UndeterminedPK201000138A0
Owner:ALMIRALL SA
New benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
UndeterminedPK201000186A0
Owner:LES LAB SERVIER SA
3-arylquinazolin-4-one compounds for combating invertebrate pests.
UndeterminedPK201000157A0
Owner:BASF SE
A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment
UndeterminedPK201000215A0
Owner:SANOFI AVENTIS SA
Pharmaceutical composition comprising VX478 and a water soluble vitamin E compound
UndeterminedPK140556A
Owner:GLAXO GROUP LTD
Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation and therapeutic use thereof
UndeterminedPK201000394A0
Owner:SANOFI AVENTIS SA
Antibody molecules having binding specificity for human IL-13
UndeterminedPK201000174A0
Owner:UCB PHARMA SA
Antimicrobial quinoline-compound parenteral composition
UndeterminedPK140722A
Owner:TAIGEN BIOTECHNOLOGY CO LTD
A method for detection of human papillomavirus (HPV) type
UndeterminedPK201000349A0
Owner:UNILABS TELELABS
N-(3,5-bis-trifluoromethyl-benzoyl)-2 benzyl-4-(azanaphthoyl-amino) piperidine compound
UndeterminedPK140682A
Owner:NOVARTIS AG
Rice transgenic event 17053 and methods of use thereof
UndeterminedPK201000253A0
Owner:MONSANTO TECHNOLOGY LLC
7-chloro-3-(5-{[N-ethyl-n-(2-methoxyethyl)amino]methyl}-[1,2,4]-thiadiazol-3-yl)-1-(tetrahydropyran-4-yl)methyl-1H-indole.
UndeterminedPK140561A
Owner:NV ORGANON
Enzymatic textile bleaching compositions and methods of use thereof
UndeterminedPK201000155A0
Owner:DANISCO US INC
A method for preparing polymorph of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile
UndeterminedPK140755A
Owner:TAKEDA PHARMA CO LTD
Nitrogen-containing fused heterocyclic compound.
UndeterminedPK201000143A0
Owner:EISAI R&D MANAGEMENT CO LTD
Γd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical composition containing it.
UndeterminedPK140566A
Owner:LES LAB SERVIER SA
Method and apparatus for sequestering carbon dioxide from spent gas
ActivePK201000319A0
Owner:MIDREX TECHNOLOGIES INC
Universal influenza vaccine based on recombinant modified vaccinia ankara virus (MVA)
UndeterminedPK201000423A0
Owner:PANACEA BIOTEC LTD
Inhibiting corrosion and scaling of surfaces contacted by sulfur-containing materials
UndeterminedPK201000191A0
Owner:GREEN SOURCE ENERGY LLC
A magneto-caloric thermal generator with modular configuration in which thermal modules are connectable together in the series and / or in parallel, for heating, tempering, air conditioning or refrigeration in any industrial or domestic installation.
UndeterminedPK140619A
Owner:COOLTECH APPL SAS
Method for removal of an organic amine from a hydrocarbon stream
UndeterminedPK201000369A0
Owner:LINDE AG +1
Process for the preparation of tetrahydroimidazopyridine substituted tropane compound
UndeterminedPK140739A
Owner:PFIZER INC
Composition containing oxadiazine for controlling insects or representatives of the order Acarina
UndeterminedPK140769A
Owner:SYNGENTA PARTICIPATIONS AG
Water supply system for poultry flock, at optimal temperature utilizing subsoil stable temperature.
UndeterminedPK140651A
Owner:MUHAMMAD YASIN KHAN
A pharmaceutical combination comprising n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2e-2-propenamide and 5-azacitidine
UndeterminedPK140756A
Owner:NOVARTIS AG
A beverage having an energy content of less than 17 KJ per 100g
UndeterminedPK140604A
Owner:UNILEVER PLC
8-hydroxy-5-[1-hydroxy-2-[[2-(4 methoxyphenyl)-1 methylethyl]amino]ethyl]-2(1H) quinoline
UndeterminedPK140703A
Owner:CHIESI FARMACEUTICI SPA
Liquid formulations of salts 1-[2 (2,4-dimethylphenylsulfanyl) phenyl]piperazine
UndeterminedPK201000321A0
Owner:H LUNDBECK AS
Assembly of a portable dust fall measurement collector from indoor and outdoor atmospheric air
UndeterminedPK201000222A0
Owner:AKHTER SHAREEF +4
Method or system using biomarkers for the monitoring of a treatment
UndeterminedPK201000181A0
Owner:BOEHRINGER INGELHEIM INT GMBH
Device for separating a finely divided solid in suspension in a viscous liquid
UndeterminedPK140760A
Owner:ENI SPA +1
Humanized antibodies specific for the protofibrillar form of beta-amyloid peptide
ActivePK201000393A0
Owner:SANOFI AVENTIS SA
Substituted thieno[3,2-B]pyrrole-5-carboxylic acid amide compound
UndeterminedPK140637A
Owner:AVENTIS PHARMACEUTICALS INC
3-Z-[1-[4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)anilino-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinon-monoethansulfonate and the use thereof as a pharmaceutical composition
UndeterminedPK140665A
Owner:BOEHRINGER INGELHEIM PHARMA GMBH & CO KG
Identification and authentication using polymeric liquid crystal material markings
ActivePK201000234A0
Owner:SICPA HOLDING SA
Substituted biphenyl-4-sulfonyl decahydroisoquinoline compound
UndeterminedPK140686A
Owner:SANOFI AVENTIS DEUT GMBH
A device for preventing the explosion of an electric transformer.
UndeterminedPK140643A
Owner:MAGNIER PHILIPPE
Method to boost mesenchymal stem cells therapeutic potential for the treatment of alzheimer's disease
PendingPK202600767A0
Owner:KANWAL HANEEF
Method for cellular tissue multiplication from jatropha curcas
UndeterminedPK201000320A0
Owner:LUCIA ATEHORTUA GARCES +1
New compounds for the treatment of cns disorders
UndeterminedPK201000244A0
Owner:BOEHRINGER INGELHEIM INT GMBH
Methods and intermediates for preparing pharmaceutical agents
UndeterminedPK201000262A0
Owner:COMSATS INST OF INFORMATION TECH
Anticancer Activity of Motesanib in Hepatocellular Carcinoma
PendingPK202600765A0
Owner:AMBER ILYAS +2
Novel crystalline polymorph form Of (2S) (4E)-N-methyl-5-[3-(5 isopropoxypyridin)yl]-4-penten-2-amine
UndeterminedPK140718A
Owner:TARGACEPT INC
Anti-mesothelin immunoconjugates and uses thereof
UndeterminedPK201000248A0
Owner:BAYER SCHERING PHARMA AG
A sustained-release composition comprising a water soluble physiologically active peptide
UndeterminedPK140577A
Owner:TAKEDA PHARMA CO LTD
Catalyst for oligomerization of ethylene, method for preparation thereof and process for oligomerization using it
UndeterminedPK140724A
Owner:LINDE AG +1
Pharmaceutically accepatable salt and solvate of triazolopyridinylsulfanyl compound as p38 MAP kinase inhibitor
UndeterminedPK140728A
Owner:PFIZER INC
N-[(6-azabicyclo]oct-5-yl)arylmethyl]heterobenzamide derivatives, preparation and therapeutic use thereof
UndeterminedPK201000197A0
Owner:SANOFI AVENTIS SA
A method for solidification of an aqueous waste material containing hazardous contaminants to pass regulatory mandated analytical tests.
UndeterminedPK140608A
Owner:AMCOL INTERNATIONAL CORP
Use of a rare earth for the removal of antimony and bismuth
UndeterminedPK201000303A0
Owner:MOLYCORP MINERALS LLC
Pharmaceutically acceptable salt of bicyclic 6-alkylidene-penem.
UndeterminedPK140554A
Owner:WYETH LLC